SCHEMBL30727059

SCHEMBL30727059

C[C@]1(CN(Cc2ccccc2)Cc2ccccc2)CC2(CCC1=O)OCCO2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.37
RORC P51449 2/20 0.35
NPSR1 Q6W5P4 4/20 0.34
ALDH1A1 P00352 4/20 0.33
C5AR1 P21730 1/20 0.33
ICMT O60725 1/20 0.32
HTT P42858 1/20 0.32
TSHR P16473 3/20 0.32
DDB1 Q16531 1/20 0.32
CRBN Q96SW2 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ATM Q13315 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
MAOB P27338 1/20 0.32
CYP2C9 P11712 2/20 0.31
CYP2C19 P33261 2/20 0.31
USP2 O75604 1/20 0.31
POLB P06746 1/20 0.31
CYP3A4 P08684 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27165059 1.00 LMNA (0.37) LMNARORCNPSR1ALDH1A1C5AR1
SCHEMBL26983676 0.85 LMNA (0.37) LMNARORCNPSR1ALDH1A1C5AR1
SCHEMBL30726987 0.85 LMNA (0.37) LMNARORCNPSR1ALDH1A1C5AR1
SCHEMBL30727014 0.75 LMNA (0.34) LMNARORCNPSR1ALDH1A1C5AR1
SCHEMBL26990598 0.75 LMNA (0.34) LMNARORCNPSR1ALDH1A1C5AR1
SCHEMBL9981990 0.70 METAP2 (0.30)
SCHEMBL10257396 0.70 CYP1A2 (0.39) NPSR1ALDH1A1ICMTTSHRTDP1
SCHEMBL30727008 0.68 C5AR1 (0.36) LMNANPSR1ALDH1A1C5AR1HTT
SCHEMBL26983576 0.68 C5AR1 (0.36) LMNANPSR1ALDH1A1C5AR1HTT
SCHEMBL14498503 0.67 POLB (0.30) POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4739680-A1 SOLID FORMS OF TRPV4 ANTAGONISTS Actio Biosciences, Inc. (US) 2026-05-13 EP disclosed
EP-4551572-A1 THERAPEUTIC COMPOUNDS AND METHODS Actio Biosciences, Inc. (US) 2025-05-14 EP disclosed
CN-119790051-A Therapeutic compounds and methods 爱克堤欧生物科学股份有限公司 2025-04-08 CN disclosed
WO-2025014818-A1 SOLID FORMS OF GSK2798745, A TRPV4 ANTAGONIST ACTIO BIOSCIENCES, INC. (US) 2025-01-16 WO disclosed
WO-2024011214-A1 THERAPEUTIC COMPOUNDS AND METHODS ACTIO BIOSCIENCES, INC. (US) 2024-01-11 WO disclosed